All In MedTech

Device Trial Radar · NCT06064071

Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

Last checked: Nov 21, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Sep 18, 2023

Primary completion

Sep 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Candela CorporationNot on our public-company list
Sponsor type
Industry
First posted
Oct 3, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Clinical Study Evaluating Nordlys™ System with Selective Waveband Technology (SWT)® Intense Pulsed Light (IPL) Applicators for Dry Eye Disease (DED) due to Meibomian Gland Dysfunction (MGD).

Conditions

  • Meibomian Gland Dysfunction
  • Dry Eye Disease

Interventions

  • Nordlys SWT IPLDevice

    Nordlys™ System with Selective Waveband Technology (SWT)® IPL Applicators

  • Meibomian Gland Expression (MGX)Procedure

    Meibomian glands are squeezed (by applying force on the inner and outer surfaces of the eyelid with a specially designed forceps, Q-tips, or fingers) in order to unclog obstructed glands and evacuate their content (the meibum), which in MGD is often viscous and thus causing obstruction

  • Sham Nordlys SWT IPLDevice

    Sham treatment with Nordlys™ System with Selective Waveband Technology (SWT)® IPL Applicators device turned off

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Improvement of Tear Breakup Time (TBUT) from baseline to 4-week follow-upTime frame: Baseline, 4-Week Follow Up (Week 10)

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • Center for Excellence in Eye Care

    Miami, Florida

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.